Projects per year
Projects 2000 2023
Active
A Phase 2B/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss
10/9/18 → 10/30/23
Project: Research project
Alopecia Areata
Alopecia
Scalp
Placebos
Safety
Intergrated Behavioral Healthcare in Dermatology: A C-Located Care Pilot Study.
Hordinsky, M. K. & Berge, J. M.
10/1/18 → 9/30/19
Project: Research project
Dermatology
Delivery of Health Care
A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata
8/6/18 → 8/30/23
Project: Research project
Alopecia Areata
Safety
baricitinib
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis
6/15/18 → 6/30/22
Project: Research project
Alopecia Areata
Alopecia
Multicenter Studies
Suspensions
Placebos
Alopecia Areata
Multicenter Studies
Safety
Diffuse alopecia
Alopecia Areata
Multicenter Studies
Placebos
Safety
Alopecia
Tablets
Placebos
2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido(4,3-b)indol-5(2H)-yl)acetic acid
Mechanism of immune modulation by DPCP in alopecia
NATIONAL ALOPECIA AREATA FOUNDATION
1/1/16 → 6/30/20
Project: Research project
Alopecia Areata
Alopecia Areata
Phosphates
Placebos
INCB018424
Alopecia
Research
A Randomized, Double-Blind Clinical Trial to Evaluate th
11/17/09 → 12/31/20
Project: Research project
Alopecia
Clinical Trials
Safety
Tacrolimus
Atopic Dermatitis
Ointments
Pediatrics
Safety